--- title: "Protocol Deviation, Definition | MedTech Terms" description: "Departure from the approved clinical investigation plan. Plain-English Clinical & Trials definition for MedTech teams, with examples and related terms." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/protocol-deviation#term", "name": "Protocol Deviation", "description": "A protocol deviation is any change, divergence, or departure from the study design or procedures defined in the clinical investigation plan that does not have prior IRB/EC approval.", "url": "https://medtechterms.com/terms/protocol-deviation", "termCode": "protocol-deviation", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/protocol-deviation#article", "headline": "Protocol Deviation", "description": "Departure from the approved clinical investigation plan.", "url": "https://medtechterms.com/terms/protocol-deviation", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/protocol-deviation" }, "about": { "@id": "https://medtechterms.com/terms/protocol-deviation#term" }, "articleSection": "Clinical & Trials", "inLanguage": "en", "keywords": "Protocol Deviation, Clinical & Trials, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "ICH E6(R3) Guideline", "url": "https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf", "publisher": { "@type": "Organization", "name": "ICH" } }, { "@type": "CreativeWork", "name": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/", "publisher": { "@type": "Organization", "name": "NIH" } }, { "@type": "CreativeWork", "name": "ICH Guidelines", "url": "https://www.ich.org/page/ich-guidelines", "publisher": { "@type": "Organization", "name": "ICH" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/iso-14155#term", "name": "ISO 14155", "url": "https://medtechterms.com/terms/iso-14155" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ich-gcp#term", "name": "ICH E6 Good Clinical Practice", "alternateName": "GCP", "url": "https://medtechterms.com/terms/ich-gcp" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/irb#term", "name": "Institutional Review Board", "alternateName": "IRB", "url": "https://medtechterms.com/terms/irb" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Clinical & Trials", "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials" }, { "@type": "ListItem", "position": 4, "name": "Protocol Deviation", "item": "https://medtechterms.com/terms/protocol-deviation" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/protocol-deviation#faq", "mainEntity": [ { "@type": "Question", "name": "What is the primary difference between a protocol deviation and a protocol amendment?", "acceptedAnswer": { "@type": "Answer", "text": "A protocol deviation is an unplanned departure from the approved protocol, while a protocol amendment is a formal, planned change to the protocol that receives prior IRB/EC approval before implementation." } }, { "@type": "Question", "name": "When is a protocol deviation considered significant?", "acceptedAnswer": { "@type": "Answer", "text": "A deviation is generally considered significant if it affects the rights, safety, or welfare of subjects, or if it impacts the integrity, reliability, or scientific validity of the study data. The specific criteria for significance are often defined within the study protocol or by regulatory guidelines." } }, { "@type": "Question", "name": "Who is responsible for identifying and reporting protocol deviations?", "acceptedAnswer": { "@type": "Answer", "text": "The investigator and study staff are primarily responsible for identifying and documenting protocol deviations. The investigator is also responsible for reporting significant deviations to the IRB/EC and sponsor, as per regulatory requirements and the study protocol." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials) 6. / 7. Protocol Deviation [All terms](/terms) Clinical & Trials [Clinical Evidence](/ecosystems/clinical-evidence) # Protocol Deviation Departure from the approved clinical investigation plan. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition A protocol deviation is any change, divergence, or departure from the study design or procedures defined in the [clinical investigation plan](/terms/cip) that does not have prior [IRB](/terms/irb)/EC approval. What the regulation says Regulatory bodies such as the FDA (21 CFR Part 312, Subpart D, and 21 CFR Part 812, Subpart C) and the EU [MDR](/terms/mdr-reporting) (Article 62 and Annex I, Section 2) mandate that clinical investigations adhere to approved protocols. Protocol deviations, particularly those impacting subject safety, rights, well-being, or data reliability, must be reported to the [Institutional Review Board](/terms/irb) (IRB) or Ethics Committee (EC) and the study sponsor. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6(R2) guideline for [Good Clinical Practice](/terms/gcp) (GCP) also emphasizes the importance of protocol adherence and the proper documentation and reporting of deviations. ## What this means in practice Significant deviations affecting subject safety, rights, welfare, or data integrity must be reported to the [IRB](/terms/irb)/EC and sponsor. Trends in deviations indicate a need for site retraining or protocol amendment. ## Examples - A clinical research coordinator administers a study drug at a dose slightly different from that specified in the protocol for one patient, without prior approval. - A subject in a clinical trial misses a scheduled follow-up visit, and the visit window specified in the protocol is exceeded. - An investigator enrolls a subject who meets most, but not all, of the pre-defined inclusion criteria outlined in the clinical investigation plan. Common pitfalls - • Failing to document minor deviations can obscure patterns indicating systemic issues or protocol flaws. - • Not assessing the impact of a deviation on subject safety or data integrity can lead to overlooking serious risks. - • Delaying the reporting of significant deviations can result in non-compliance and compromise study validity. - • Ignoring repeated deviations at a site may indicate inadequate training or a need for protocol clarification rather than isolated incidents. - • Misinterpreting which deviations require immediate reporting can lead to under-reporting or unnecessary administrative burdens. ## Frequently asked questions What is the primary difference between a protocol deviation and a protocol amendment? A protocol deviation is an unplanned departure from the approved protocol, while a protocol amendment is a formal, planned change to the protocol that receives prior [IRB](/terms/irb)/EC approval before implementation. When is a protocol deviation considered significant? Who is responsible for identifying and reporting protocol deviations? ## Cross-references ### Part of A larger framework or document this term belongs to. - [ ISO 14155 ](/terms/iso-14155) ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Clinical & Trials Institutional Review Board(IRB) Board that reviews and approves human-subjects research at an institution. ](/terms/irb)[ Standards ISO 14155 Good clinical practice for clinical investigations of medical devices. ](/terms/iso-14155)[ Clinical & Trials ICH E6 Good Clinical Practice(GCP) International standard for the design, conduct, and reporting of clinical trials. ](/terms/ich-gcp) ### Clinical Trials & Evidence · From this learning path [ Clinical & Trials Investigator Brochure(IB) Compilation of clinical and nonclinical information on an investigational device given to clinical investigators, establishes what's 'anticipated' for UADE determinations. Adjacent lesson ](/terms/investigator-brochure?from=clinical-trials-and-evidence)[ Clinical & Trials Primary and Secondary Endpoints The pre-specified outcomes that determine trial success (primary), provide supporting evidence (secondary), or generate hypotheses (exploratory). Adjacent lesson ](/terms/primary-secondary-endpoint?from=clinical-trials-and-evidence)[ Clinical & Trials Adaptive Trial Design Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data. ](/terms/adaptive-trial?from=clinical-trials-and-evidence)[ Clinical & Trials Adverse Event(AE) Any untoward medical occurrence in a subject, whether or not related to the device. ](/terms/adverse-event?from=clinical-trials-and-evidence) ### More in Clinical & Trials · Same category [ Clinical & Trials Clinical Evaluation Report(CER) Documented assessment of clinical data demonstrating EU MDR conformity for a device. ](/terms/cer) Cited by Where this term appears across MedTech Terms. Learning paths (1) - [Clinical Trials & Evidence](/paths/clinical-trials-and-evidence)Lesson 9 of 18 Ecosystems (1) - [Clinical Evidence](/ecosystems/clinical-evidence) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 ICH· 2 NIH· 1 1. [1 ICH E6(R3) Guideline Verified ICH · database.ich.org ](https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf) 2. [2 ClinicalTrials.gov Verified NIH · clinicaltrials.gov ](https://clinicaltrials.gov/) 3. [3 ICH Guidelines Verified ICH · ich.org ](https://www.ich.org/page/ich-guidelines) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Clinical evidence intersecting with device security? We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Clinical & Trials Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=protocol-deviation) Learn in 60 seconds Card Lesson Quiz Departure from the approved clinical investigation plan. - · Significant deviations affecting subject safety, rights, welfare, or data integrity must be reported to the IRB/EC and sponsor. - · Trends in deviations indicate a need for site retraining or protocol amendment. Remember this Watch out: Failing to document minor deviations can obscure patterns indicating systemic issues or protocol flaws. Related terms - [ISO 14155 ](/terms/iso-14155) - [ICH E6 Good Clinical Practice(GCP) ](/terms/ich-gcp) - [Institutional Review Board(IRB) ](/terms/irb) You may also need Auto-suggested from Clinical & Trials and shared keywords. - [Clinical Investigation Plan(CIP) ](/terms/cip) - [IDE Annual Progress Report ](/terms/ide-annual-report) - [Investigator Brochure(IB) ](/terms/investigator-brochure) - [Feasibility Study ](/terms/feasibility-study) - [IDE Supplement ](/terms/ide-supplement) - [Investigator-Initiated Trial(IIT) ](/terms/investigator-initiated-trial) [All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials) From the Blue Goat network Related resources and services on this topic. - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)